Announcements

Stakeholder Consultation on the Proposed Regulation for Complementary Health Products under the Health Products Act

Public Consultations

HSA Investigating First Suspected Transnational Etomidate Vaporiser Pod Supply Syndicate under Tobacco and Vaporisers Control Act

Press Releases

Regulatory Update for Therapeutic Product Registration (30 June 2026)

Extension of e-labelling to P and GSL medicines

Regulatory Updates

Keynote Address by Adj Prof (Dr) Raymond Chua, Chief Executive Officer, Health Sciences Authority, on "Regulatory Innovation as a Catalyst for Global Medtech Growth" for Singapore Medical Device Venture Showcase

Speeches

HSA and SRC Honours More Than 2,200 Blood Donors and Organisations, and Launches HealthPoints and yuu Points for Blood Donors at World Blood Donor Day

Press Releases

Healthpoints and Yuu Points

A concise summary of the main points regarding this article.

Feature Articles

Recall of BD ChloraPrep™ 1 mL Applicator – Clear

Retail-level recall of four batches of BD ChloraPrep™ 1 mL Applicator – Clear due to potential breach of sterility in the packaging

Product Recalls

Mean applicant screening response time

HSA’s target screening turn-around-time from the date of receipt of the application dossier to the date of acceptance or non-acceptance/withdrawal of the application (excluding applicant’s response time) is 50 working days (WD).

Regulatory Updates

Skin products from dubious or unknown sources can cause serious adverse effects

Consumer Safety Articles

Beware of supposedly herbal or natural products

Consumer Safety Articles